Previous 10 | Next 10 |
Broad-Spectrum Antimicrobial Benefits Include 60-Second Kill Time and No Rinse Required PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today announced its PURE® Hard Surface disinfectant (EPA Reg. No. 729...
Superior SDC-Based, Non-Toxic, Broad-Spectrum Antimicrobial Offers Kill Times as Fast as 30 Seconds PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today announced it received a purchase order to ship EPA-regis...
Update on SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period ended January 31, 202...
Update on Business Segments and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented, non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal first quarter ended O...
Update on Business Segments and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal year ended July 31, 20...
Thinly traded nano cap PURE Bioscience ( OTC:PURE +12.5% ) is up on a 4x surge in volume, albeit on turnover of only 82K shares, following its announced initiatives to accelerate its path to profitability by Q4. More news on: PURE Bioscience, Inc., Healthcare stocks news, Stocks on the...
Tom Y. Lee Appointed Acting CEO PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that the Board of Directors has taken a number of initiatives to accelerate its goal of reaching profitability in c...
PURE Bioscience, Inc. (PURE) Q3 2019 Results Conference Call June 13, 2019 04:30 PM ET Company Participants Terri MacInnis - VP, IR, Bibicoff + MacInnis, Inc. Hank Lambert - CEO Mark Elliott - VP, Finance Tom Myers - COO Conference Call Participants Christian Bozorth - Ka...
PURE Bioscience ( OTC:PURE ): Q3 GAAP EPS of -$0.03. More news on: PURE Bioscience, Inc., Earnings news and commentary, Energy stocks news, , Read more ...
Update on SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal third quarter and nine-month period ended April 30, 2019....
News, Short Squeeze, Breakout and More Instantly...
July 14 th -17 th , 2023, Long Beach, California Booth #429 PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, is set to unveil its newest food safety solutions at the 2024 International Association f...
PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, and AgroVet Alliance, FZE (“AVA”), have entered into a multi-year international...
Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...